Posts filtered by tags: Epstein-Barr[x]


 

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).
Tags: Health, Epstein Barr, Wistar Institute


A future mono vaccine may have a shot at defeating multiple sclerosis, a new study suggests

Particles of the mononucleosis virus (dark circles) inside a cell.CDC A study provides the strongest evidence to date suggesting the Epstein-Barr virus may lead to multiple sclerosis.  Scientists disagree about whether EBV definitively causes MS. Experts hope a vaccine may one day prevent some MS cases, but it may take decades. Scientists have found the strongest evidence to date that an infection from the Epstein-Barr virus could significantly increase the risk of developing multiple scleros...
Tags: UK, Science, News, Trends, Multiple Sclerosis, Harvard, News UK, National Institutes of Health, Vaccine, Thompson, University College London, Epidemiology, Epstein Barr, EBV, Harvard T H Chan School of Public Health, Alan Thompson


Could the 'Mono' Virus Help Trigger Multiple Sclerosis?

By Amy Norton HealthDay ReporterFRIDAY, Jan. 14, 2022 (HealthDay News) -- For years, researchers have suspected that the Epstein-Barr virus, best...
Tags: Epstein Barr, Amy Norton HealthDay


Health Highlights: Jan. 14, 2022

By Ernie Mundell HealthDay ReporterCould the 'mono' virus be a cause of MS? Researchers have long suspected that the Epstein-Barr virus might play...
Tags: Epstein Barr, Ernie Mundell HealthDay ReporterCould


Coffee and Provocation

Badger Archeologist A trove of 200 Roman-era coins was discovered in northwestern Spain thanks to a hungry badger hunting for food inside a cave. Greenland Protects Itself Greenland has permanently banned all oil and gas exploration. Greenland previously banned the import of all dogs into  western Greenland north of the  Arctic Circle  and entire eastern Greenland  in order to preserve the genetic base of Greenland sled dogs. Autoimmune Disorders May Be Diet Related The global spread of...
Tags: UK, Scotland, Pets, Spain, Greenland, Quebec, Arctic Circle, Epstein Barr, PBurns, Terrierman, Burning Mountain New South Wales Australia, Conifer Plantations Are Harming Red Squirrels, Pine Martins


Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr virus (EBV), according to a study led by Harvard T.H. Chan School of Public Health researchers.
Tags: Health, Epstein Barr, EBV, Harvard T H Chan School of Public Health


Epstein-Barr Virus Found To Trigger Multiple Sclerosis

An anonymous reader quotes a report from Scientific American: A connection between the human herpesvirus Epstein-Barr and multiple sclerosis (MS) has long been suspected but has been difficult to prove. Epstein-Barr virus (EBV) is the primary cause of mononucleosis and is so common that 95 percent of adults carry it. Unlike Epstein-Barr, MS, a devastating demyelinating disease of the central nervous system, is relatively rare. It affects 2.8 million people worldwide. But people who contract infe...
Tags: Tech, Stanford University, Epstein Barr, EBV, Epstein, Lawrence Steinman, William H Robinson, Alberto Ascherio


Beyond COVID-19 vaccines, mRNA's pioneers have big plans for using the technology against a range of diseases

BI Graphics Employees in special suits test procedures for manufacturing the messenger RNA (mRNA) COVID-19 vaccine from Pfizer-BioNTech, in Marburg, Germany. Abdulhamid Hosbas/Anadolu Agency via Getty Images Drugmakers big and small are storming into messenger RNA research. The technology behind the first COVID-19 vaccines could help fight other diseases, including cancer. Early leaders in the mRNA space include Moderna, BioNTech, Pfizer, Sanofi, and GlaxoSmitKline. This artic...
Tags: Massachusetts, Trends, University of Pennsylvania, GlaxoSmithKline, Pfizer, Epstein Barr, Sanofi, GSK, Chikungunya, Rockville Maryland, Paul Hudson, Moderna, Andrew Dunn, Stéphane Bancel, BioNtech, COVID


Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Two recently published studies available on the National Institutes of Health website indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases.
Tags: Health, National Institutes of Health, Epstein Barr


Long COVID and severe COVID-19 infections associated with Epstein-Barr virus reactivation

Two recently published studies indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. A study in Pathogens found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation. A study in Scientific Reports by Nature found EBV reactivation was also associated with COVID-19 severity.
Tags: Science, Epstein Barr, EBV


Epstein-Barr virus reactivation may be the cause of long COVID symptoms

Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to coronavirus infection may be the cause of previously unexplained long COVID symptoms -- such as fatigue, brain fog, and rashes -- that occur in approximately 30% of patients after recovery from initial COVID-19 infection.
Tags: Health, Epstein Barr, EBV


Long COVID symptoms likely caused by Epstein-Barr virus reactivation

Epstein-Barr virus (EBV) reactivation may be the cause of previously unexplained long COVID symptoms -- such as fatigue, brain fog, and rashes -- that occur in approximately 30% of patients after recovery from initial COVID-19 infection. The first evidence linking EBV reactivation to long COVID, as well as an analysis of long COVID prevalence, is outlined in a new long COVID study published in the journal Pathogens.
Tags: Science, Epstein Barr, EBV


Sick and tired: UCLA professor chases the history of fatigue through the centuries

It’s defined as a lack of energy, but carries heavy emotional baggage in go-go, can-do America: If you’re fatigued, you’re weak. Lethargic. Idle. “Sloth” is condemned by the church as one of the seven deadly sins. Emily Abel (Courtesy UCLA) Today, as millions of people with “long COVID” report brain fog and exhaustion that linger months after “recovering” from illness, UCLA Fielding School of Public Health professor emerita Emily Abel chases the history of fatigue through the centuries in h...
Tags: Health, Books, News, Medicine, La, America, Sport, Public Health, Soccer, Virginia Woolf, Ucla, Epstein Barr, LA County, Abel, North Hollywood, UCLA Fielding School of Public Health


Sick and tired: Former UCLA professor chases the history of fatigue through the centuries

It’s defined as a lack of energy, but carries heavy emotional baggage in go-go, can-do America: If you’re fatigued, you’re weak. Lethargic. Idle. “Sloth” is condemned by the church as one of the seven deadly sins. Emily Abel (Courtesy UCLA) Today, as millions of people with “long COVID” report brain fog and exhaustion that linger months after “recovering” from illness, UCLA Fielding School of Public Health professor emerita Emily Abel chases the history of fatigue through the centuries in h...
Tags: Health, Books, News, Medicine, La, America, Sport, Public Health, Soccer, Virginia Woolf, Ucla, Epstein Barr, LA County, Abel, North Hollywood, UCLA Fielding School of Public Health


Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

A Hong Kong Baptist University-led research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV).
Tags: Health, Epstein Barr, Hong Kong Baptist University


HKBU develops dual-targeting drug for EBV-related cancers

A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV).
Tags: Science, Epstein Barr, EBV, Hong Kong Baptist University, HKBU


Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS).
Tags: Health, Epstein Barr


NIH-funded study examines mono, chronic fatigue syndrome in college students

Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS). A longitudinal study from DePaul University and Northwestern University followed 4,501 college students to examine risk factors that may trigger longer illness.
Tags: Science, Nih, Northwestern University, Epstein Barr, DePaul University


Scientists make pivotal discovery on mechanism of Epstein-Barr virus latent infection

Wistar Researchers have discovered a new enzymatic function of the Epstein-Barr Virus (EBV) protein EBNA1, a critical factor in EBV's ability to transform human cells and cause cancer. Study provides new indications for inhibiting EBNA1 function, opening up fresh avenues for development of therapies to treat EBV-associated cancers.
Tags: Science, Epstein Barr, EBV, Epstein Barr Virus EBV, Wistar Researchers


The US just authorized Moderna's coronavirus vaccine, making millions more doses available to help curb the pandemic

Moderna; Samantha Lee/Business Insider US regulators have authorized a second coronavirus vaccine for emergency use.  This two-dose vaccine, developed by the biotech firm Moderna and the US National Institutes of Health, was about 94% effective at preventing COVID-19 in a large clinical trial. Moderna's vaccine is easier to store and transport than Pfizer's COVID-19 shot, which got US clearance a week ago. Moderna plans to deliver 20 million doses in the US by year's end.  The authorizati...
Tags: Health, Science, News, China, Massachusetts, Russia, US, Trends, United States, Healthcare, Astrazeneca, Fda, Pfizer, University of Oxford, Anthony Fauci, Low


Multiple sclerosis as the flip side of immune fitness

About half of the people with multiple sclerosis have the HLA-DR15 gene variant. A study led by the University of Zurich has now shown how this genetic predisposition contributes to the development of the autoimmune disease multiple sclerosis in combination with environmental factors. The decisive factor is the shaping of a repertoire of immune cells which - although they are effective in fighting off pathogens such as Epstein-Barr virus - also attack brain tissue.
Tags: Science, Epstein Barr, University of Zurich


A new therapeutic approach for Epstein-Barr virus-associated tumors

A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that exosomes derived from Vδ2-T cells (Vδ2-T-Exos) can effectively control Epstein-Barr virus-associated tumours and induce T-cell anti-tumour immunity.
Tags: Health, Epstein Barr, Exos


HKUMed develops a novel therapeutic approach against Epstein-Barr virus-associated tumours

A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that exosomes derived from Vδ2-T cells (Vδ2-T-Exos) can effectively control Epstein-Barr virus-associated tumours and induce T-cell anti-tumour immunity. The novel findings of Vδ2-T-Exos provide insights into new therapeutic approach for Epstein-Barr virus (EBV)-associated tumours. The ground-breaking findings have been published in the leading academic journal, Science Translational Medicine.
Tags: Science, Epstein Barr, EBV, Exos


35 of the most dangerous things science has strongly linked to cancer

Research technician Ashwini Balakrishnan works in the immunotherapy research lab of Dr. Stanley Riddell at the Fred Hutchinson Cancer Research Center in Seattle. Elaine Thompson/AP All cancers are a result of damage or genetic mutations in our DNA. But the many reasons individual cancer cases pop up in people are complex. Some are genetic and passed down from one generation to the next, and others are a result of things in our environment that we inhale, eat, or use. Visit Business Insider...
Tags: UK, New York, London, California, Cdc, France, China, New York City, US, Trends, Iran, Ukraine, Earth, United States, Harvard University, New York Times


EBV viral genome alters the host epigenetic landscape to drive stomach cancer

he Epstein-Barr virus (EBV), one of the most common human viruses, is associated with about 8-10 per cent of stomach -- or gastric -- cancers, the third leading cause of cancer death globally.
Tags: Health, Epstein Barr, EBV


Epstein-Barr virus rewires host epigenomes to drive stomach cancer

Researchers in Japan and Singapore have discovered a molecular mechanism that explains how Epstein-Barr virus (EBV) infection alters a host's epigenome to promote tumorigenesis (the transformation of normal cells into cancer cells) in certain types of stomach cancer. The findings suggest that EBV infection plays an important role in the development of EBV-associated stomach cancers, and provide fresh insights that may lead to new therapies for stomach and other virus-related malignancies.
Tags: Japan, Science, Singapore, Epstein Barr, EBV


An ancient piece of chewing gum offers surprising insights into the human genome

Researchers recently uncovered a piece of chewed-on birch pitch in an archaeological dig in Denmark.Conducting a genetic analysis of the material left in the birch pitch offered a plethora of insights into the individual who last chewed it.The gum-chewer has been dubbed Lola. She lived 5,700 years ago; and she had dark skin, dark hair, and blue eyes. None Five thousand and seven hundred years ago, "Lola" — a blue-eyed woman with dark skin and hair — was chewing on a piece of pitch derived from...
Tags: Europe, Dna, Genetics, Innovation, Evolution, Denmark, Scandinavia, Lola, Epstein Barr, Birch, Lolland, Human body, Hannes Schroeder, Theis Jensen


Sequencing an anciet girl's genome from a 5,700-year-old piece of chewing gum

Almost 6,000 years ago on the island of Lolland, Denmark, a young girl disposed of her chewing gum. Now, University of Copenhagen researchers have used that gum, made from birch pitch, to sequence the girl's full genome. From Science: The child had black hair, blue eyes, and dark skin, and was more closely related to hunter-gatherers from Western Europe than to farmers who had more recently settled in the region. She left traces of her most recent meal in the gum—she had been chewing hazel...
Tags: Post, Science, News, Biology, Genetics, Gum, Chewing Gum, Western Europe, Epstein Barr, University of Copenhagen, Lolland Denmark


How the immune system keeps the Epstein-Barr virus in check

A protein called PD-1, which is found on immune cells called CD8+ T cells, plays a key role in controlling infection with the Epstein-Barr virus, according to a study published May 30 in the open-access journal PLOS Pathogens by Christian Münz of the University of Zurich, and colleagues. The results from this study indicate that monitoring PD-1 signaling during future vaccination and immunotherapy studies may inform patient outcomes.
Tags: Science, Epstein Barr, University of Zurich, PLOS Pathogens, Christian Münz


Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine

The Epstein-Barr virus (EBV) is estimated to infect a large part of the population and is associated with a variety of human tumors; therefore, EBV is an important target for vaccine development. In this issue of the JCI, Rühl et al. developed a promising heterologous prime-boost vaccination strategy for EBV-associated malignancies and symptomatic primary infection. The authors show that two prime-boost regimens, using either dendritic cells or an adenovirus approach targeting nuclear antigen EB...
Tags: Epstein Barr, EBV, Sandhya Sharma, Rayne H. Rouce, Ankara MVA, Sandhya Sharma Rayne H Rouce